Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer
Clinical trial NCT05435274 · UNKNOWN
Trial details
- NCT number
- NCT05435274
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2024-10-07
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.